Therapeutic Area Market Research Reports & Industry Analysis

The Therapeutic Area Market refers to a specific category of diseases or conditions for which there are known medical treatments or promising treatments in development. It is a way to classify drugs without reference to the type of therapy, form of action, or the company that makes it, but instead to look at the disease it treats.

Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.

Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.

...Show More ...Show Less


Therapeutic Area Industry Research & Market Reports

  • Intrauterine Devices

    ... CAGR of 3.8% over the analysis period 2024-2030. Hormonal Progestogen-Releasing IUD, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.4 Billion by the end of the ... Read More

  • Cardiovascular Ultrasound Systems

    ... at a CAGR of 5.1% over the analysis period 2024-2030. Stress Echocardiogram, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$1.0 Billion by the end of ... Read More

  • Cognitive Assessment and Training

    ... 2030, growing at a CAGR of 26.9% over the analysis period 2024-2030. Cognitive Assessment & Training Solutions, one of the segments analyzed in the report, is expected to record a 24.9% CAGR and reach US$17.4 ... Read More

  • C-Reactive Protein Testing

    ... at a CAGR of 1.7% over the analysis period 2024-2030. Cardiovascular Diseases, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$1.0 Billion by the end of ... Read More

  • Dermatology Devices

    ... CAGR of 9.5% over the analysis period 2024-2030. Treatment Devices, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$20.5 Billion by the end of the analysis ... Read More

  • Heart Valve Repair and Replacement Devices

    ... reach US$40.9 Billion by 2030, growing at a CAGR of 15.4% over the analysis period 2024-2030. Transcatheter Surgery, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach ... Read More

  • Ophthalmic Pharmaceutical Drugs

    ... at a CAGR of 3.6% over the analysis period 2024-2030. Anti-VEGF Agents, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$34.3 Billion by the end of ... Read More

  • Ophthalmic Femtosecond Lasers

    ... at a CAGR of 4.6% over the analysis period 2024-2030. Consumables & Accessories, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$666.4 Million by the end ... Read More

  • Peptic Ulcer Drugs

    ... at a CAGR of 2.2% over the analysis period 2024-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 2.0% CAGR and reach US$2.6 Billion by the end of the ... Read More

  • Gastroparesis Drugs

    ... CAGR of 4.8% over the analysis period 2024-2030. Idiopathic Gastroparesis Drugs, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.3 Billion by the end of the ... Read More

  • Kaposi Sarcoma

    ... CAGR of 3.2% over the analysis period 2024-2030. HAART, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$101.5 Million by the end of the analysis period. ... Read More

  • Cartilage Repair / Cartilage Regeneration

    ... Billion by 2030, growing at a CAGR of 15.1% over the analysis period 2024-2030. Cell-based Treatment Modality, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$2.3 ... Read More

  • Cervical Total Disc Replacement Devices

    ... Billion by 2030, growing at a CAGR of 18.3% over the analysis period 2024-2030. Metal-on-BiocompatibleMaterial, one of the segments analyzed in the report, is expected to record a 19.2% CAGR and reach US$9.4 Billion by ... Read More

  • Cervical Cancer Diagnostic Testing

    ... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Pap Smear Testing, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$5.3 Billion by ... Read More

  • Colposcopy

    ... 3.9% over the analysis period 2024-2030. Optical Instrument, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$580.3 Million by the end of the analysis period. Growth ... Read More

  • Cranial Fixation and Stabilization Systems

    ... Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Cranial Stabilization Systems, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$987.5 ... Read More

  • Gastrointestinal Therapeutics

    ... CAGR of 5.1% over the analysis period 2024-2030. Crohn`s Disease Therapeutics, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$19.0 Billion by the end of the ... Read More

  • Gastrointestinal Stents

    ... CAGR of 5.9% over the analysis period 2024-2030. Biliary Stents, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$382.2 Million by the end of the analysis ... Read More

  • Immuno-Oncology

    ... 16.2% over the analysis period 2024-2030. Immune Checkpoint Inhibitors, one of the segments analyzed in the report, is expected to record a 16.2% CAGR and reach US$75.1 Billion by the end of the analysis period. ... Read More

  • Neurovascular Devices / Interventional Neurology

    ... Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2024-2030. Aneurysm Coiling & Embolization Devices, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and ... Read More

  • Orthodontic Services

    ... CAGR of 11.4% over the analysis period 2024-2030. Removable Orthodontic Services, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$7.7 Billion by the end of the ... Read More

  • Lacrimal Duct Stent Tubes

    ... 2030, growing at a CAGR of 2.1% over the analysis period 2024-2030. Bicanalicular Tubes, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$35.0 Million by the ... Read More

  • Stroke Management

    ... CAGR of 5.3% over the analysis period 2024-2030. Diagnostics Type, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$35.9 Billion by the end of the analysis ... Read More

  • Urology Lasers

    ... CAGR of 6.7% over the analysis period 2024-2030. Holmium, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$749.4 Million by the end of the analysis period. ... Read More

  • Therapeutic Respiratory Devices

    ... at a CAGR of 3.3% over the analysis period 2024-2030. Positive Airway Pressure Devices, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$32.3 Billion by the ... Read More

Cookie Settings